1. Home
  2. JACS vs LFCR Comparison

JACS vs LFCR Comparison

Compare JACS & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JACS
  • LFCR
  • Stock Information
  • Founded
  • JACS 2024
  • LFCR 1986
  • Country
  • JACS United States
  • LFCR United States
  • Employees
  • JACS N/A
  • LFCR N/A
  • Industry
  • JACS
  • LFCR Biotechnology: Pharmaceutical Preparations
  • Sector
  • JACS
  • LFCR Health Care
  • Exchange
  • JACS NYSE
  • LFCR Nasdaq
  • Market Cap
  • JACS 303.6M
  • LFCR 308.8M
  • IPO Year
  • JACS 2024
  • LFCR N/A
  • Fundamental
  • Price
  • JACS $10.33
  • LFCR $8.30
  • Analyst Decision
  • JACS
  • LFCR Buy
  • Analyst Count
  • JACS 0
  • LFCR 4
  • Target Price
  • JACS N/A
  • LFCR $8.00
  • AVG Volume (30 Days)
  • JACS 73.5K
  • LFCR 224.7K
  • Earning Date
  • JACS 01-01-0001
  • LFCR 08-25-2025
  • Dividend Yield
  • JACS N/A
  • LFCR N/A
  • EPS Growth
  • JACS N/A
  • LFCR N/A
  • EPS
  • JACS N/A
  • LFCR N/A
  • Revenue
  • JACS N/A
  • LFCR $130,309,000.00
  • Revenue This Year
  • JACS N/A
  • LFCR $1.64
  • Revenue Next Year
  • JACS N/A
  • LFCR $2.91
  • P/E Ratio
  • JACS $267.37
  • LFCR N/A
  • Revenue Growth
  • JACS N/A
  • LFCR 7.23
  • 52 Week Low
  • JACS $9.94
  • LFCR $3.68
  • 52 Week High
  • JACS $10.41
  • LFCR $8.85
  • Technical
  • Relative Strength Index (RSI)
  • JACS N/A
  • LFCR 62.25
  • Support Level
  • JACS N/A
  • LFCR $8.10
  • Resistance Level
  • JACS N/A
  • LFCR $8.32
  • Average True Range (ATR)
  • JACS 0.00
  • LFCR 0.39
  • MACD
  • JACS 0.00
  • LFCR 0.04
  • Stochastic Oscillator
  • JACS 0.00
  • LFCR 71.05

About JACS JACKSON ACQUISITION COMPANY II

Jackson Acquisition Co II is a newly incorporated blank check company.

About LFCR Lifecore Biomedical Inc.

Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.

Share on Social Networks: